Benzyl 3-aminopyrrolidine-1-carboxylate

Catalog No. :
ACKEGB251
CAS No. :
185057-50-5
Molecular Formula :
C12H16N2O2
Molecular Weight :
220.27

IUPAC Name:benzyl 3-aminopyrrolidine-1-carboxylate

Benzyl 3-aminopyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g97%$79.00Login to see priceIn stockInquiry
25g97%$164.00Login to see priceIn stockInquiry
100g97%$473.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 3-aminopyrrolidine-1-carboxylate
IUPAC Namebenzyl 3-aminopyrrolidine-1-carboxylate
MDL No.MFCD03001673
Molecular FormulaC12H16N2O2
Molecular Weight220.27
SMILESO=C(N1CC(N)CC1)OCC2=CC=CC=C2
InChI KeyFPXJNSKAXZNWMQ-UHFFFAOYSA-N
SynonymN-Cbz-3-aminopyrrolidine;BENZYL 3-AMINOPYRROLIDINE-1-CARBOXYLATE;1-N-CBZ-3-AMINO-PYRROLIDINE;1-CBZ-3-AMINO PYRROLIDINE;3-AMINO-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER;3-AMINO-1-N-CBZ-PYRROLIDINE;1-Benzyloxycarbonyl-3-aminopyrrolidine, 97%;1-cbz-3-aminopyrrolidine HCl or 1-benzyloxycarbonyl-3-aminopyrrolidine HCl
CAS No.185057-50-5
PubChem CID2756614

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACKEGB251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKEGB251 route product structure diagram
    ACKEGB251185057-50-5 In Stock
Inquiry

2. ACKEGB251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBAUS147 route compound structure diagram
    ACBAUS1472923-16-2 In Stock
  6. Then
  7. ACKEGB251 route product structure diagram
    ACKEGB251185057-50-5 In Stock
Inquiry

Comments (0)